Conatus Pharmaceuticals CFO Susan Knudson's 2022 pay jumps 26% to $681K
Conatus Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: May 1, 2023
Conatus Pharmaceuticals reported fiscal year 2022 executive compensation information on May 1, 2023.
In 2022, three executives at Conatus Pharmaceuticals received on average a compensation package of $508K, a 8% increase compared to previous year.
Susan A. Knudson, Chief Financial Officer, received $681K in total, which increased by 26% compared to 2021. 68% of Knudson's compensation, or $466K, was in salary. Knudson also received $187K in non-equity incentive plan and $28K in option awards.
Steven J. Mento, Chief Executive Officer, received a compensation package of $560K, which increased by 40% compared to previous year. 95% of the compensation package, or $532K, was in salary.
Joyce Reyes, Senior Vice President of Regulatory, Quality, Clinical Operations & Technical Operations, earned $281K in 2022.